Form 8-K - Current report:
SEC Accession No. 0001493152-22-034460
Filing Date
2022-12-05
Accepted
2022-12-05 16:05:52
Documents
22
Period of Report
2022-11-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 63561
2 ex10-1.htm EX-10.1 51749
3 ex10-2.htm EX-10.2 54569
4 ex10-3.htm EX-10.3 175187
5 ex10-4.htm EX-10.4 112227
6 ex99-1.htm EX-99.1 1903
7 ex99-2.htm EX-99.2 2041
8 ex99-1_001.jpg GRAPHIC 1348388
9 ex99-1_002.jpg GRAPHIC 404973
10 ex99-2_001.jpg GRAPHIC 577309
11 ex99-2_002.jpg GRAPHIC 78584
  Complete submission text file 0001493152-22-034460.txt   4049874

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE ocx-20221130.xsd EX-101.SCH 3224
13 XBRL LABEL FILE ocx-20221130_lab.xml EX-101.LAB 34240
14 XBRL PRESENTATION FILE ocx-20221130_pre.xml EX-101.PRE 22358
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3461
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 221444977
SIC: 2835 In Vitro & In Vivo Diagnostic Substances